KTA-V IT

Organization name

Schwabe Pharma Italia

SRN

IT-MF-000029129

Manufacturer status

Active

Certificate health across this manufacturer's portfolio.

6 warnings recorded — scroll inside the panel to see all entries.

• CW032

  EUDAMED did not publish a description for this code.
• CW135

  EUDAMED did not publish a description for this code.
• CW010

  EUDAMED did not publish a description for this code.
• CW999

  Non utilizzare se presente ipersensibilità o allergia individuale verso uno o più componenti.
• CW999

  1 ml di KalobaTUSS adulti contiene 0,70 g di fruttosio. Se il medico le ha detto che è intollerante ad alcuni zuccheri, o se ha una diagnosi di intolleranza ereditaria al fruttosio, una rara malattia genetica per cui i pazienti non riescono a trasformare il fruttosio, parli con il medico prima di prendere questo dispositivo medico.
• CW999

  Consultare il medico se i sintomi persistono.

Primary placement in Italy; available across 1 country total.

Trade name

not provided

UDI-DI code

08057157500046

Basic UDI-DI

80571575000000000000001NV

Reference / catalog number

KTA-V IT

Issuing entity

GS1

Risk category

Class IIa

Applicable legislation

MDR [Regulation (EU) 2017/745 on medical devices]

Status

On the market

Quantity

1

Additional product description

—

Additional information URL

No additional information URL provided by the manufacturer.

Clinical sizes

No clinical sizes registered for this device.

• Batch number
• Expiration date
• Manufacturing date
• Serial number
• Software identification

European Medical Device Nomenclature — the EU product classification assigned to this device.

• V9017ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES